Business

RepliCel's Licensee Building Momentum in China with Facility and Team

RepliCel's Licensee Building Momentum in China with Facility and Team.

articleReplicel Life Sciences Inc.March 26, 20193/company/replicel-life-sciences-inc/news/replicels-licensee-building-momentum-in-china-with-facility-and-team
RepliCel's Licensee Building Momentum in China with Facility and Team

About this update from Replicel Life Sciences Inc.

[{"type":"text","content":"\n\n\n\nRepliCel's Licensee Building Momentum in China with Facility and Team\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prntac{\nTEXT-ALIGN: CENTER\n}\n\n\n\n\n\n\nRepliCel's Licensee Building Momentum in China with Facility and Team\nCanada NewsWire\nVANCOUVER, March 26, 2019\n\n\n\nYOFOTO (China) Health Announces Initiation of Facility Build-Out, New Hires, and Preparation to Submit Applications to China's Regulators\n VANCOUVER, March 26, 2019 /CNW/ - RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP) (FRA:P6P2) (\"RepliCel\" or the \"Company\"), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that its Licensee, YOFOTO (China) Health Co. (\"YOFOTO\"), headquartered in Ningbo, China, is rapidly building momentum on its licensed programs for Greater China, since closing the transaction with RepliCel in October last year.\n\n \n \n\n \nIn a recent update to the RepliCel Board of Directors, the YOFOTO team reported it had:\ncompleted the facility design and engineering plans for a laboratory, clinic, and research manufacturing facility build-out to be done in a building it already owns near its headquarters in Ningbo as well as new construction of an adjacent building for administration; obtained the necessary regulatory permits and approvals to commence certain demolition and construction; retained the contractors; commenced construction of a 4,700 sq metre facility in its existing building to hold clinical research manufacturing, material handling, purified water processing, research and development labs, QC/QA testing, cryopreservation storage, clinical biopsy/treatment space, and an exhibition hall; and hired several team members for its new cell therapy division and are engaged in recruiting several others for QC/QA, clinical, operations and regulatory positions.YOFOTO has announced that by mid-2019 it expects to have:\nhired over 20 people; completed primary facility construction and initiated technology transfer, training, and validation testing; and submitted the initial regulatory documentation to the Chi...

More updates from Replicel Life Sciences Inc.